Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances topic
No spam. Unsubscribe anytime.
Kansas House passes ban on kratom after hours of debate and personal testimony
Summary
The House adopted the conference report on House Bill 2365, banning kratom and related preparations after lengthy floor debate and emotional personal accounts from lawmakers and constituents who urged regulation rather than an outright ban.
Get email alerts on the Controlled Substances topic
No spam. Unsubscribe anytime.
Representative Will Carpenter moved adoption of the conference committee report on House Bill 2365, a measure that would ban the sale and distribution of kratom and related preparations in Kansas. The bill cleared the House after prolonged debate and a recorded vote of 76 in favor and 49 opposed.
Supporters, including Carpenter, framed the bill as a public-safety response to rising emergency-room visits and overdoses connected to adulterated or synthetically altered products. They said the measure seeks to prevent an emerging public-health threat and protect young people who can easily buy kratom derivatives at convenience stores.
Opponents and several legislators urged caution. Representative Susan Ruiz, who said she had received many emails and first-person accounts, told colleagues the committee hearing did not capture the full picture of how thousands of Kansans use kratom as self-care for chronic pain, addiction recovery and other conditions. Ruiz said, "Don't ban this. Don't make the thousands of Kansas who are using it criminals," and urged regulation with guardrails rather than an outright prohibition.
Other lawmakers raised a range of concerns. Representative Haskins and Representative Meyer recounted constituents whose lives reportedly improved on kratom and urged stricter regulation, including age limits and product standards, to keep products away from youth without criminalizing responsible adults. Representative Droy stressed the need for scientific study and standardized processing, saying "we need to purify it. We need to evaluate the effects, develop the dosage, determine the safety." Representative Bryce, an emergency-department practitioner, urged colleagues to weigh psychiatric effects he has observed and supported the ban.
During floor remarks, speakers noted that a mix of states has taken different approaches: some have scheduled the compounds, others have banned them outright, and dozens have regulatory frameworks. Representative Carpenter said the measure reflects recommendations from law enforcement and state regulatory boards and that several states and agencies have moved to restrict components of the market.
The House recorded the final vote after the sponsor closed debate. The clerk reported "76 having voted in favor and 49 against the passage of House Bill 2365; the bill is hereby declared passed." The bill will now proceed to the Senate or to any final steps required for enactment.
What happens next: supporters said the measure is intended to reduce poisonings and emergency-room admissions; opponents signaled they would continue pushing for narrow regulatory alternatives and for preserving research pathways. The House debate made clear the policy divide: sponsors argued a ban is the quickest tool to reduce acute harms, while critics argued a ban risks criminalizing long-term responsible users and harms ongoing research.

